{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:18:39Z","timestamp":1791065919992,"version":"4.1.0"},"reference-count":51,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T00:00:00Z","timestamp":1260835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cry1Ac protoxin from <jats:italic>Bacillus thuringiensis<\/jats:italic> is a potent mucosal immunogen and adjuvant. When delivered intranasally (i.n.) Cry1Ac elicits significant antibody response and is able to improve vaccination against <jats:italic>Naegleria fowleri<\/jats:italic> infection, but the functional effects occurring in nasal lymphocytes when this protein is administered alone have not been determined. Here, we investigated the effects of i.n. immunization with Cry1Ac on antibody production, lymphocyte activation and cytokine production in lymphocytes from nasal\u2010associated lymphoid tissue (NALT) and nasal passages (NP). Our results show that i.n. immunization with Cry1Ac induced significant specific IgA and IgG cell responses, especially in NP. Besides, it increased the proportion of lymphocytes expressing the activation markers CD25 and CD69 in both nasal tissues, but differently. CD25 was increased in B cells along with CD4 and CD8 T cells from NALT and NP, while CD69 was increased in B cells from both tissues but only in CD4 T cells from NP. Finally, we found that Cry1Ac augmented especially a Th2 profile of cytokines, as the proportion of T cells that spontaneously produced IL\u20104, IL\u20105 and IL\u201010 was increased and this effect was higher in NP than in NALT. These data contribute to explain the potent immunogenicity of Cry1Ac via i.n. route.<\/jats:p>","DOI":"10.1111\/j.1365-3083.2009.02358.x","type":"journal-article","created":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T10:48:58Z","timestamp":1260874138000},"page":"159-168","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Striking Activation of NALT and Nasal Passages Lymphocytes Induced by Intranasal Immunization with Cry1Ac protoxin"],"prefix":"10.1111","volume":"71","author":[{"given":"M. A.","family":"Rodriguez\u2010Monroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Moreno\u2010Fierros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2,22]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90158-4"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.65.7.2676-2684.1997"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/088282403322396091"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00299.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3346::AID-IMMU3346>3.0.CO;2-P"},{"key":"e_1_2_7_7_2","first-page":"107","article-title":"Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide\u2010based conjugate vaccine","volume":"15","author":"Hirano T","year":"2006","journal-title":"Immunol Lett"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.11.5416-5420.2001"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2006.01898.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(00)00398-1"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2003.01190.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1999.00534.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00136-8"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2000000200002"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.8.4368-4375.2004"},{"key":"e_1_2_7_16_2","first-page":"93","article-title":"Hyperexpression of a Bacillus thuringiensis delta\u2010endotoxin\u2010encoding gene in Escherichia coli: properties of the product","volume":"1","author":"Ge AZ","year":"1990","journal-title":"Gene"},{"key":"e_1_2_7_17_2","first-page":"72","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2010dye binding","volume":"7","author":"Bradford MM","year":"1976","journal-title":"Anal Biochem"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1991.tb02542.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.d01-690.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1997.d01-159.x"},{"key":"e_1_2_7_21_2","first-page":"167","article-title":"HIV mucosal vaccine: nasal immunization with rBCG\u2010V3J1 induces a long term V3J1 peptide\u2010specific neutralizing immunity in Th1\u2010 and Th2\u2010deficient conditions","volume":"15","author":"Hiroi T","year":"2001","journal-title":"J Immunol"},{"key":"e_1_2_7_22_2","first-page":"18","article-title":"Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)","volume":"1","author":"Matsuo K","year":"2000","journal-title":"Vaccine"},{"key":"e_1_2_7_23_2","first-page":"162","article-title":"Nasopharyngeal\u2010associated lymphoreticular tissue (NALT) immunity: fimbriae\u2010specific Th1 and Th2 cell\u2010regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production","volume":"15","author":"Yanagita M","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_7_24_2","first-page":"170","article-title":"Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal\u2010associated lymphoreticular tissue","volume":"15","author":"Hagiwara Y","year":"2003","journal-title":"J Immunol"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/314827"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00048-6"},{"key":"e_1_2_7_27_2","first-page":"19","article-title":"Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant\u2010combined influenza vaccine","volume":"16","author":"Asanuma H","year":"2001","journal-title":"Vaccine"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.4.97-03017"},{"key":"e_1_2_7_29_2","first-page":"20","article-title":"Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K)","volume":"4","author":"Watanabe I","year":"2002","journal-title":"Vaccine"},{"key":"e_1_2_7_30_2","first-page":"162","article-title":"Deficiency of IL\u20105 receptor alpha\u2010chain selectively influences the development of the common mucosal immune system independent IgA\u2010producing B\u20101 cell in mucosa\u2010associated tissues","volume":"15","author":"Hiroi T","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/72309"},{"issue":"3","key":"e_1_2_7_32_2","first-page":"S167","article-title":"HIV\u20101 entry at the mucosal surface: role of antibodies in protection","volume":"14","author":"Mascola JR","year":"2000","journal-title":"AIDS"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/72206"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.05.007"},{"key":"e_1_2_7_35_2","first-page":"166","article-title":"Activated antigen\u2010specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections","volume":"1","author":"Hogan RJ","year":"2001","journal-title":"J Immunol"},{"key":"e_1_2_7_36_2","first-page":"193","article-title":"Protection from respiratory virus infections can be mediated by antigen\u2010specific CD4(+) T cells that persist in the lungs","volume":"16","author":"Hogan RJ","year":"2001","journal-title":"J Exp Med"},{"key":"e_1_2_7_37_2","first-page":"167","article-title":"Antigen\u2010specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection","volume":"15","author":"Wiley JA","year":"2001","journal-title":"J Immunol"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1439"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5290-1"},{"key":"e_1_2_7_40_2","first-page":"71","article-title":"Slight influence of the estrous cycle stage on the mucosal and systemic specific antibody response induced after vaginal and intraperitoneal immunization with protoxin Cry1Ac from Bacillus thuringiensis in mice","volume":"18","author":"Moreno\u2010Fierros L","year":"2002","journal-title":"Life Sci"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7799(01)01670-5"},{"key":"e_1_2_7_42_2","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/IAI.67.12.6270-6280.1999","article-title":"Mutants of Escherichia coli heat\u2010labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells","volume":"67","author":"Ryan EJ","year":"1999","journal-title":"Infect Immun"},{"key":"e_1_2_7_43_2","first-page":"401","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"14","author":"Sallusto F","year":"1999","journal-title":"Nature"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(88)90223-X"},{"key":"e_1_2_7_45_2","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.4049\/jimmunol.133.6.2892","article-title":"Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen","volume":"133","author":"Elson CO","year":"1984","journal-title":"J Immunol"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)80100-X"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00420.x"},{"key":"e_1_2_7_48_2","first-page":"194","article-title":"Isotype\u2010specific selection of high affinity memory B cells in nasal\u2010associated lymphoid tissue","volume":"3","author":"Shimoda M","year":"2001","journal-title":"J Exp Med"},{"key":"e_1_2_7_49_2","first-page":"338","article-title":"Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T\u2010lymphocyte responses with non\u2010replicating antigens","volume":"81","author":"Bowen JC","year":"1994","journal-title":"Immunology"},{"key":"e_1_2_7_50_2","first-page":"158","article-title":"Intranasal immunization with CTL epitope peptides from HIV\u20101 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide\u2010specific CTLs and protection against tumor development in vivo","volume":"15","author":"Porgador A","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_7_51_2","first-page":"163","article-title":"MHC class I\u2010restricted cytotoxic lymphocyte responses induced by enterotoxin\u2010based mucosal adjuvants","volume":"15","author":"Simmons CP","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.06.007"}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3083.2009.02358.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3083.2009.02358.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T03:17:34Z","timestamp":1697253454000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3083.2009.02358.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,22]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1365-3083.2009.02358.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3083.2009.02358.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,22]]},"assertion":[{"value":"2010-02-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}